NCT00811603View on ClinicalTrials.gov

Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions
Cesarean SectionInfection
Interventions
DRUG

Cefazolin (Timing of Antibiotic Prophylaxis)

Patients scheduled for a cesarean delivery will be randomly assigned to receive Cefazolin (antibiotic prophylaxis) either prior to skin incision or after the clamping of the umbilical cord

Trial Locations (2)

90806

Long Beach Memorial Medical Center, Long Beach

92868

University of California, Irvine Medical Center, Orange

Sponsors

Lead Sponsor

MemorialCare
All Listed Sponsors
collaborator

University of California, Irvine

OTHER

lead

MemorialCare

OTHER

NCT00811603 - Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery | Biotech Hunter | Biotech Hunter